Company: INGN
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0000950170-25-045737
Chunk: 70

Company: Inogen Inc
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 70
---
 decisions resulting from its executive compensation review. For the first six months of 2024, the Compensation Committee retained Pearl Meyer to serve as its independent executive compensation consultant and for the last six months of 2024, the Compensation Committee retained Mercer to serve as its independent executive compensation consultant and review the competitiveness of our compensation program for our senior executive officers and non-employee directors. Mercer also advises the Compensation Committee regarding various other executive and director compensation issues, as requested.

<div align='center'>-46-</div>

No member of our management team participated in the Compensation Committee’s decision to retain Mercer. Mercer reports directly to the Compensation Committee, and the Compensation Committee may replace Mercer or hire additional consultants at any time. Mercer attends meetings of the Compensation Committee, as requested, and communicates with the Compensation Committee Chairperson between meetings; however, the Compensation Committee, or the independent members of the Board, make all decisions regarding the compensation of our executives.

Mercer provides various compensation consulting services to the Compensation Committee with respect to our executives and other key employees pursuant to a written consulting agreement with the Compensation Committee. The services Mercer provides under the agreement include advising the Compensation Committee on the principal aspects of the Company’s executive compensation program including evolving best practices and providing market information and analysis regarding the competitiveness of the Company’s executive compensation program design.

Competitive Positioning

In 2024, the Compensation Committee approved a group of peer group companies (the “Compensation Peer Group”). The Compensation Peer Group included similarly-situated medical device and diagnostic companies that were identified by Mercer as companies with similar financial and growth characteristics and as competitors for executive talent based generally on the following criteria:

Had revenue for the trailing 12 months of $100 million to $1 billion (with selected exceptions);

Had market capitalization of $100 million to $4 billion (with selected exceptions); and

Was in the healthcare equipment, supplies, providers, or services industry, which includes medical device companies

The Compensation Peer Group consisted of 19 companies that met the industry criteria and financial criteria. The following 19 companies comprised the Compensation Peer Group plan to be used to set compensation for 2024:

| Alphatec Holdings, Inc     | LeMaitre Vascular, Inc.         |
| AngioDynamics, Inc.        | Merit Medical Systems, Inc.     |
| Artivion, Inc.             | Nevro Corporation               |
| AtriCure, Inc.             | OraSure Technologies, Inc.      |
| Avanos Medical, Inc